Mail

Cannabis Stocks

Cannabis Stocks

86.21k followers • 22 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

22 Symbols

Get the Yahoo Finance app

Free real-time data
News and price alerts
Add and edit holdings
Track performance
Create multiple watchlists

Motley Fool
Is Aurora Cannabis a Buy?
Cannabis investing can be risky. Should investors put faith in the industry leader?
Motley Fool
Better Buy: AbbVie vs. Johnson & Johnson
Which stock wins in a battle between these two big pharma companies?
Thomson Reuters StreetEvents
Edited Transcript of CGC.TO earnings conference call or presentation 15-Aug-19 12:30pm GMT
Q1 2020 Canopy Growth Corp Earnings Call
Motley Fool
Weekly Cannabis Stock News: Tilray Nabs a Key EU Shipment Deal
Well, that didn't take long -- the company's recently opened facility in Portugal is about to ship product. Meanwhile, MedMen comes up with its own delivery enhancement.
The Motley Fool
2 Risky Stocks for the Dangerous Buyer
If you're willing to take the risk, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and this other stock are great options for quick gains.
The Motley Fool
3 Stocks Under $3 That Could Triple Your Money
For the recession bargain hunter, Bombardier Inc. (TSX:BBD.B) and two other stocks provide great opportunities for quick growth.
The Motley Fool
Why Canopy Growth (TSX:WEED) Could Double!
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) fell to a new low this week, and that could make the stock a very hot buy for investors today.
Simply Wall St.
Why You Might Be Interested In Molson Coors Brewing Company (NYSE:TAP) For Its Upcoming Dividend
It looks like Molson Coors Brewing Company (NYSE:TAP) is about to go ex-dividend in the next 4 days. Investors can...
Motley Fool
Better Buy: Canopy Growth vs. Tilray
Which stock wins in a one-on-one matchup between these two leading Canadian cannabis producers?
Motley Fool
Is GW Pharmaceuticals a Buy?
To buy or not to buy? That's the question for GW Pharmaceuticals. And here's the answer.
Simply Wall St.
At €85.56, Is Anheuser-Busch InBev SA/NV (EBR:ABI) Worth Looking At Closely?
Today we're going to take a look at the well-established Anheuser-Busch InBev SA/NV (EBR:ABI). The company's stock saw...
Market Realist
Cresco Labs: Target Price and Valuation Multiple
Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”
Market Realist
Financial Services for US Cannabis Firms Gaining Traction
New York’s Carolyn Maloney expressed optimism about the House approving the SAFE Banking Act. The bill would open banking access to the cannabis industry.
Motley Fool
Should You Buy or Sell Canopy Growth Right Now?
After reporting more than a billion dollars in losses, the world’s largest cannabis company might not be an attractive investment anymore.
Market Realist
Canopy Growth: Bruce Linton Is Buying, Should You?
Bruce Linton, Canopy Growth's (CGC) (WEED) former co-CEO, has acquired more stock in the company. Overall, analysts favor a “buy” rating on the stock.
Motley Fool
Why Shares of Craft Brew Alliance Are Crashing Today
A potential buyout isn't going to happen.
Market Realist
Bernie versus Joe: Who Has a Better Marijuana Campaign?
Bernie Sanders versus Joe Biden! Who do you think has a better marijuana campaign? The 2020 presidential election is heating up.
The Motley Fool
3 Marijuana Stocks to Avoid Like the Plague in August
Cannabis stocks have been sinking lower and lower, but I would especially avoid CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) and two others.
Zacks
Amgen Presents Positive Data From Rituxan Biosimilar Study
Amgen (AMGN) markets Mvasi and Kanjinti, biosimilar versions of Avastin and Herceptin, respectively in the United States, and Kanjinti and Amgevita, biosimilar of Humira, in the EU.
Simply Wall St.
Is GW Pharmaceuticals (NASDAQ:GWPH) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Motley Fool
Why the Hemp Market May Be a Waste of Time for Cannabis Companies
Charlotte's Web has done a great job in the CBD hemp market thus far, but it may not make sense for other cannabis companies to try and follow suit.
Market Exclusive
Why Did Aurora Cannabis Acquire Hempco Food and Fibre?
Following the completion of a plan of arrangement, Aurora Cannabis (NYSE: ACB) (TSX: ACB) has acquired all of the issued and outstanding common shares of Hempco Food and Fiber (TSX-V: HEMP). To acquire shares of Hempco not already owned by Aurora, the company invested approximately C$63.4 million on a fully diluted basis. Hempco is now a wholly-owned subsidiary of Aurora. The […]The post Why Did Aurora Cannabis Acquire Hempco Food and Fibre? appeared first on Market Exclusive.
Zacks
BUD vs. DVDCY: Which Stock Should Value Investors Buy Now?
BUD vs. DVDCY: Which Stock Is the Better Value Option?
Zacks
Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit
FDA approves AbbVie's (ABBV) upadacitinib to be marketed as Rinvoq. Bayer (BAYRY) is set to divest its Animal Health unit to Elanco for $7.6 billion in a cash-and-stock deal.
Motley Fool
3 Pot Stocks With a Huge International Presence
These marijuana stocks have cultivation, export, or research deals with at least one dozen countries outside of Canada.